Inovio Pharmaceuticals, Inc.
DE ˙ DB
0,96 € ↓ -0,06 (-6,32%)
2026-06-04
AKTIENPREIS
SecurityDE:GBM / Inovio Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership63,864 shares
Latest Disclosed Value $ 111,125
Morgan Stanley reports 39.65% decrease in ownership of GBM / Inovio Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 63,864 shares of Inovio Pharmaceuticals, Inc. (DE:GBM) valued at $91,964 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 105,828 shares of Inovio Pharmaceuticals, Inc.. This represents a change in shares of -39.65% during the quarter. The current value of the position is $61,086 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 63,864 -41,964 -39.65 111 -39.67 0.0000
2026-05-27 2025-12-31 13F/A-1 INOVIO PHARMACEUTICALS COM SHS 45773H409 105,828 -680,946 -86.55 184 -90.01 0.0000
2026-02-13 2025-12-31 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 105,828 -680,946 184 0.0000
2026-05-27 2025-09-30 13F/A-1 INOVIO PHARMACEUTICALS COM SHS 45773H409 786,774 384,912 95.78 1,841 125.34 0.0001
2025-11-14 2025-09-30 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 786,774 384,912 1,841 0.0001
2025-08-15 2025-06-30 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 401,862 117,219 41.18 818 76.46 0.0001
2025-05-15 2025-03-31 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 284,643 151,366 113.57 464 90.53 0.0000
2025-05-15 2024-12-31 13F/A-1 INOVIO PHARMACEUTICALS COM SHS 45773H409 133,277 38,145 40.10 244 -55.74 0.0000
2025-02-14 2024-12-31 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 133,277 38,145 244 0.0000
2025-05-14 2024-09-30 13F/A-2 INOVIO PHARMACEUTICALS COM SHS 45773H409 95,132 -8,574 -8.27 550 -34.41 0.0000
2025-02-14 2024-09-30 13F/A-1 INOVIO PHARMACEUTICALS COM SHS 45773H409 95,132 -8,574 550 0.0000
2024-11-14 2024-09-30 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 95,132 -8,574 550 0.0000
2025-05-14 2024-06-30 13F/A-2 INOVIO PHARMACEUTICALS COM SHS 45773H409 103,706 34,832 50.57 838 -12.36 0.0001
2024-10-17 2024-06-30 13F/A-1 INOVIO PHARMACEUTICALS COM SHS 45773H409 103,706 34,832 838 0.0001
2024-08-14 2024-06-30 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 103,706 34,832 838 0.0001
2024-10-17 2024-03-31 13F/A-2 INOVIO PHARMACEUTICALS COM SHS 45773H409 68,874 68,874 956 0.0001
2024-08-16 2024-03-31 13F/A-1 INOVIO PHARMACEUTICALS COM SHS 45773H409 68,874 68,874 956 0.0000
2024-05-15 2024-03-31 13F INOVIO PHARMACEUTICALS COM SHS 45773H409 68,874 68,874 956 0.0001
2014-08-12 2014-06-30 13F INOVIO PHARMACEUTICALS COM 45773H102 0 -1,833,823 -100.00 0 -100.00
2014-05-13 2014-03-31 13F INOVIO PHARMACEUTICALS COM 45773H102 1,833,823 957,802 109.34 6,107 140.43 0.0026
2014-02-13 2013-12-31 13F INOVIO PHARMACEUTICALS COM 45773H102 876,021 -85,227 -8.87 2,540 27.64 0.0011
2013-11-13 2013-09-30 13F INOVIO PHARMACEUTICALS COM 45773H102 961,248 450,848 88.33 1,990 390.15 0.0009
2013-08-08 2013-06-30 13F INOVIO PHARMACEUTICALS COM 45773H102 510,400 510,400 406 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.